c‐Maf activates the promoter and enhancer of the IL‐21 gene, and TGF‐β inhibits c‐Maf‐induced IL‐21 production in CD4+ T cells

Previous studies have shown that IL‐6 potently induces IL‐21 production in CD4+ T cells, whereas TGF‐β inhibits IL‐6‐induced IL‐21 production in CD4+ T cells. In this study, we addressed the mechanisms underlying the transcriptional regulation of IL‐21 production in CD4+ T cells. We found that IL‐6 induced c‐Maf expression in CD4+ T cells and that the enforced expression of c‐Maf induced IL‐21 production in CD4+ T cells without IL‐6, IL‐4/STAT6 signaling, or an autocrine effect of IL‐21. Moreover, we found that c‐Maf directly bound to and activated IL‐21P and the CNS‐2 enhancer through MARE sites. On the other hand, we also found that although TGF‐β up‐regulated IL‐6‐induced c‐Maf expression in CD4+ T cells, TGF‐β inhibited c‐Maf‐induced IL‐21 production in CD4+ T cells. Finally, we found that Foxp3 bound to IL‐21P and the CNS‐2 enhancer and inhibited c‐Maf‐induced IL‐21 production modestly but significantly in CD4+ T cells. Taken together, these results suggest that c‐Maf induces IL‐21 production directly in CD4+ T cells by activating IL‐21P and the CNS‐2 enhancer and that TGF‐β suppresses c‐Maf‐induced IL‐21 production in CD4+ T cells.

[1]  Xiaojing Ma.  Faculty Opinions recommendation of Cutting edge: IL-27 induces the transcription factor c-Maf, cytokine IL-21, and the costimulatory receptor ICOS that coordinately act together to promote differentiation of IL-10-producing Tr1 cells. , 2009 .

[2]  V. Kuchroo,et al.  Cutting Edge: IL-27 Induces the Transcription Factor c-Maf, Cytokine IL-21, and the Costimulatory Receptor ICOS that Coordinately Act Together to Promote Differentiation of IL-10-Producing Tr1 Cells1 , 2009, The Journal of Immunology.

[3]  Casey T. Weaver,et al.  TGF-β Promotes Th17 Cell Development through Inhibition of SOCS31 , 2009, The Journal of Immunology.

[4]  Zhihong Wu,et al.  c-Maf Regulates IL-10 Expression during Th17 Polarization1 , 2009, The Journal of Immunology.

[5]  Thomas Korn,et al.  IL-17 and Th17 Cells. , 2009, Annual review of immunology.

[6]  V. Kuchroo,et al.  The costimulatory molecule ICOS regulates the expression of c-Maf and IL-21 in the development of follicular T helper cells and TH-17 cells , 2009, Nature Immunology.

[7]  G. Bhagat,et al.  IRF-4-binding protein inhibits interleukin-17 and interleukin-21 production by controlling the activity of IRF-4 transcription factor. , 2008, Immunity.

[8]  D. Hwang,et al.  Generation of T Follicular Helper Cells Is Mediated by Interleukin-21 but Independent of T Helper 1, 2, or 17 Cell Lineages (DOI: 10.1016/j.immuni.2008.05.009) , 2008 .

[9]  C. Mackay,et al.  A fundamental role for interleukin-21 in the generation of T follicular helper cells. , 2008, Immunity.

[10]  D. Hwang,et al.  Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages. , 2008, Immunity.

[11]  A. Yoshimura,et al.  Foxp3 Inhibits RORγt-mediated IL-17A mRNA Transcription through Direct Interaction with RORγt*♦ , 2008, Journal of Biological Chemistry.

[12]  T. Nakayama,et al.  Development and characterization of IL-21–producing CD4+ T cells , 2008, The Journal of experimental medicine.

[13]  Yuelei Shen,et al.  TGF-β-induced Foxp3 inhibits TH17 cell differentiation by antagonizing RORγt function , 2008, Nature.

[14]  C. Mackay,et al.  T follicular helper (TFH) cells in normal and dysregulated immune responses. , 2008, Annual review of immunology.

[15]  W. Leonard,et al.  Interleukin-21: basic biology and implications for cancer and autoimmunity. , 2008, Annual review of immunology.

[16]  M. Neurath,et al.  IL‐21 regulates experimental colitis by modulating the balance between Treg and Th17 cells , 2007, European journal of immunology.

[17]  D. Levy,et al.  IL-6 programs TH-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways , 2007, Nature Immunology.

[18]  Terry B. Strom,et al.  IL-21 initiates an alternative pathway to induce proinflammatory TH17 cells , 2007, Nature.

[19]  A. D. Panopoulos,et al.  Essential autocrine regulation by IL-21 in the generation of inflammatory T cells , 2007, Nature.

[20]  S. Reiner.  Development in Motion: Helper T Cells at Work , 2007, Cell.

[21]  Lawrence Steinman,et al.  A brief history of TH17, the first major revision in the TH1/TH2 hypothesis of T cell–mediated tissue damage , 2007, Nature Medicine.

[22]  S. Akira,et al.  IL-21–induced Bɛ cell apoptosis mediated by natural killer T cells suppresses IgE responses , 2006, The Journal of experimental medicine.

[23]  C. Dong.  Diversification of T-helper-cell lineages: finding the family root of IL-17-producing cells , 2006, Nature Reviews Immunology.

[24]  W. Leonard,et al.  Interleukin-21: a modulator of lymphoid proliferation, apoptosis and differentiation , 2005, Nature Reviews Immunology.

[25]  W. Leonard,et al.  Calcium-dependent Activation of Interleukin-21 Gene Expression in T Cells* , 2005, Journal of Biological Chemistry.

[26]  J. Ochando,et al.  IL-6 Plays a Unique Role in Initiating c-Maf Expression during Early Stage of CD4 T Cell Activation1 , 2005, The Journal of Immunology.

[27]  M. Grusby,et al.  NFATc2 and T-bet contribute to T-helper-cell-subset-specific regulation of IL-21 expression. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[28]  M. Grusby,et al.  Biology of IL‐21 and the IL‐21 receptor , 2004, Immunological reviews.

[29]  U. Dianzani,et al.  Transcriptional regulation of th2 differentiation by inducible costimulator. , 2003, Immunity.

[30]  A. Satoskar,et al.  Interleukin 21 Is a T Helper (Th) Cell 2 Cytokine that Specifically Inhibits the Differentiation of Naive Th Cells into Interferon γ–producing Th1 Cells , 2002, The Journal of experimental medicine.

[31]  L. Glimcher,et al.  Transcription Tantalizing Times for T Cells , 2002, Cell.

[32]  L. Glimcher,et al.  Interferon Regulatory Factor 4 (IRF4) Interacts with NFATc2 to Modulate Interleukin 4 Gene Expression , 2002, The Journal of experimental medicine.

[33]  M. Collins,et al.  IL-21 limits NK cell responses and promotes antigen-specific T cell activation: a mediator of the transition from innate to adaptive immunity. , 2002, Immunity.

[34]  A. Grinberg,et al.  DNA sequence‐dependent folding determines the divergence in binding specificities between Maf and other bZIP proteins , 2001, The EMBO journal.

[35]  Scott R. Presnell,et al.  Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function , 2000, Nature.

[36]  Druin Burch,et al.  On Work , 2000, The Lancet.

[37]  L. Glimcher,et al.  The transcription factor c-Maf controls the production of interleukin-4 but not other Th2 cytokines. , 1999, Immunity.

[38]  L. Glimcher,et al.  c-maf Promotes T Helper Cell Type 2 (Th2) and Attenuates Th1 Differentiation by Both Interleukin 4–dependent and –independent Mechanisms , 1998, The Journal of experimental medicine.

[39]  Laurie H Glimcher,et al.  The Proto-Oncogene c-maf Is Responsible for Tissue-Specific Expression of Interleukin-4 , 1996, Cell.

[40]  S. Akira,et al.  Essential role of Stat6 in IL-4 signalling , 1996, Nature.

[41]  K. Kataoka,et al.  Maf nuclear oncoprotein recognizes sequences related to an AP-1 site and forms heterodimers with both Fos and Jun , 1994, Molecular and cellular biology.

[42]  K. Kataoka,et al.  Structure-function analysis of the maf oncogene product, a member of the b-Zip protein family , 1993, Journal of virology.

[43]  Martin Bachmann,et al.  Disruption of the murine IL-4 gene blocks Th2 cytokine responses , 1993, Nature.

[44]  J. Abrams,et al.  Anti-IL-6 monoclonal antibodies protect against lethal Escherichia coli infection and lethal tumor necrosis factor-alpha challenge in mice. , 1990, Journal of immunology.